C. De Schutter et al. / Tetrahedron 69 (2013) 5920e5926
5923
1.34 (d, J 6.4 Hz, 6H), 1.33 (d, J 6.4 Hz, 6H), 1.04 (t, J 7.3 Hz, 3H); 19
F
261.3, 216.7 Hz), 74.1 (d, J 7.0 Hz), 74.0 (d, J 7.0 Hz), 40.7 (td, J 21.3,
15.1 Hz), 38.3, 37.7, 24.2, 23.9, 22.3 (td, J 5.5, 5.5 Hz). MS-ESI (m/z)
[MþNa]þ 321 (18), 279 (40), 237 (100). HRMS-ESI (m/z) [MþNa]þ
calcd for C12H21O4F2PNa 321.1043, found 321.1039.
NMR (CDCl3, 376 MHz)
NMR (CDCl3, 161 MHz)
d
ꢁ112.84 (dt, J 108.2 Hz, 19.6 Hz, 2F); 31P
d
4.9 (t, J 108.2 Hz, 1P); 13C NMR (CDCl3,
101 MHz) d 208.9, 120.3 (td, J 259.1, 217.9 Hz), 73.7 (d, J 7.1 Hz), 36.1,
33.7 (td, J 9.0, 4.6 Hz), 28.1 (td, J 21.5, 15.7 Hz), 24.2 (d, J 3.3 Hz), 23.8
(d, J 4.8 Hz), 7.9. MS-ESI (m/z) [MþNa]þ 323 (54), 281 (50), 239
(100), 221 (8). HRMS-ESI (m/z) [MþNa]þ calcd for C12H23O4PF2Na
323.1194, found 323.1200.
4.6. Diisopropyl difluoro(3-oxocyclohexyl)methyl-
phosphonate (6a)45
Following the general procedure used for 2a from iododi-
fluorophosphonate 1a (50.0 mg, 0.15 mmol), 2-cyclohexenone
(0.017 mL, 0.18 mmol), and Et3B (0.18 mL) in CH2Cl2 (1 mL), com-
pound 6a was isolated after flash chromatography (EtOAc/pentane
5:5) as a colourless oil (28.4 mg, 62%). 1H NMR (CDCl3, 400 MHz)
4.3. Diisopropyl 1,1-difluoro-2-methyl-4-
oxohexylphosphonate (3a)
Following the general procedure used for 2a from iododi-
fluorophosphonate 1a (100 mg, 0.29 mmol), trans-4-hexen-3-one
(0.037 mL, 0.32 mmol), and Et3B (0.36 mL) in CH2Cl2 (2 mL),
compound 3a was isolated after flash chromatography (EtOAc/
pentane 2:8 to 3:7) as a colourless oil (45.2 mg, 49%). 1H NMR
d
4.84 (dsept, J 6.2, 6.2 Hz, 1H), 4.83 (dsept, J 6.2, 6.2 Hz, 1H),
2.58e2.44 (m, 1H), 2.68e1.61 (m, 8H), 1.37 (d, J 6.2 Hz, 6H), 1.36 (d, J
6.2 Hz, 6H); 19F NMR (CDCl3, 376 MHz)
d
ꢁ115.81 (ddd, J 299.1,108.1,
13.5 Hz, 1F), ꢁ118.02 (ddd, J 299.1, 108.1, 15.9 Hz, 1F); 31P NMR
(CDCl3, 400 MHz)
d
4.78 (dsept, J 6.9, 6.9 Hz, 2H), 3.03e2.36 (m, 2H),
(CDCl3, 161 MHz) d
4.6 (t, J 108.1 Hz, 1P); 13C NMR (CDCl3, 101 MHz)
2.95e2.79 (m, 1H), 2.53e2.36 (m, 2H), 1.38e1.36 (m, 12H), 1.09 (d, J
d 209.0, 120.0 (td, J 263.0, 214.2 Hz), 73.9 (d, J 5.5 Hz), 73.8 (d, J
6.9 Hz, 3H), 1.06 (t, J 7.3 Hz, 3H); 19F NMR (CDCl3, 376 MHz)
5.7 Hz), 42.8 (td, J 20.6, 15.3 Hz), 41.1, 39.9 (td, J 7.9, 4.7 Hz), 24.3,
24.2, 23.8. MS-ESI (m/z) [MþH]þ 313 (40), 271 (100), 229 (75).
HRMS-ESI (m/z) [MþH]þ calcd for C13H24O4F2P 313.1380, found
313.1391.
d
ꢁ114.88 (ddd, J 297.4, 110.5, 17.1 Hz, 1F), ꢁ116.47 (ddd, J 297.4,
110.5, 17.1 Hz, 1F); 31P NMR (CDCl3, 161 MHz)
5.1 (t, J 110.5 Hz, 1P);
13C NMR (CDCl3, 101 MHz)
208.8, 121.5 (td, J 262.8, 213.9 Hz), 73.8
d
d
(d, J 7.2 Hz), 73.7 (d, J 7.2 Hz), 42.2 (td, J 7.3, 4.0 Hz), 36.6, 33.8 (td, J
20.4, 15.5 Hz), 24.3, 23.9, 13.4, 7.8. MS-ESI (m/z) [MþNa]þ 337 (19),
295 (43), 253 (100), 235 (19). HRMS-ESI (m/z) [MþNa]þ calcd for
C13H25O4PF2Na 337.1356, found 337.1355.
4.7. Diisopropyl difluoro(3-oxocycloheptyl)methyl-
phosphonate (7a)
Following the general procedure used for 2a from iododi-
fluorophosphonate 1a (200.0 mg, 0.58 mmol), 2-cyclohepten-1-
one (0.080 mL, 0.72 mmol), and Et3B (0.72 mL) in CH2Cl2 (4 mL),
compound 7a was isolated after flash chromatography (EtOAc/
pentane 4:6) as a colourless oil (83.0 mg, 57%). 1H NMR (CDCl3,
4.4. Diisopropyl (2-acetylcyclohexyl)di-
fluoromethylphosphonate (4a)
General procedure for the radical conjugate addition. To a stirred
solution of iododifluoromethylphosphonate 1a (50 mg, 0.15 mmol),
and 1-acetylcyclohexene (0.023 mL, 0.18 mmol) in CH2Cl2 (1 mL)
was added Et3B (0.18 mL, 1 M in hexane, 1.2 equiv). After 1 h of
stirring, Et3B was added (0.18 mL, 1 M in hexane, 1.2 equiv) and the
mixture was stirred additional 1 h. The mixture was then concen-
trated under reduced pressure. Compound 4a was isolated after
flash chromatography (EtOAc/pentane 2:8) as a colourless oil
(23.9 mg, 48%) in a cis/trans mixture (92:8). 1H NMR (CDCl3,
400 MHz) d 4.87e4.81 (m, 2H), 2.82 (dd, J 15.1, 2.4 Hz, 1H), 2.61 (dd,
J 15.1, 11.6 Hz, 1H), 2.52e2.48 (m, 2H), 2.47e2.37 (m, 1H), 2.36e1.40
(m, 6H), 1.38 (d, J 6.0 Hz, 6H), 1.37 (d, J 6.0 Hz, 6H); 19F NMR (CDCl3,
376 MHz)
298.6, 109.4, 17.3 Hz, 1F); 31P NMR (CDCl3, 161 MHz)
109.4 Hz, 1P); 13C NMR (CDCl3, 101 MHz)
211.8, 120.9 (td, J 264.6,
d
ꢁ113.33 (ddd, J 298.6, 109.4, 15.6 Hz, 1F), ꢁ116.02 (ddd, J
d
5.0 (t, J
d
213.9 Hz), 73.9 (d, J 7.3 Hz), 73.8 (d, J 7.3 Hz), 43.5, 42.5, 41.3 (td, J
19.9,15.6 Hz), 29.0, 28.4, 24.4, 24.2, 23.7. MS-ESI (m/z) [MþNa]þ 349
(5), 307 (19), 265 (100). HRMS-ESI (m/z) [MþNa]þ calcd for
C14H25O4F2PNa 349.1356, found 349.1356.
400 MHz)
1H), 2.43e2.23 (m, 1H), 2.19 (s, 3H), 1.90e1.24 (m, 8H), 1.36 (m,
12H); 19F NMR (CDCl3, 376 MHz)
d 4.82 (dsept, J 6.3, 6.3 Hz, 2H), 3.16 (ddd, J 4.1, 4.1, 4.1 Hz,
d
ꢁ103.08 (dd, J 298.5,106.3 Hz,1F,
trans), ꢁ110.00 (dd, J 298.5, 107.9 Hz, 1F, cis), ꢁ112.77 (ddd, J 298.5,
107.9, 24.1 Hz, 1F, cis), ꢁ118.80 (ddd, J 298.5, 106.3, 23.9 Hz, 1F,
4.8. Diisopropyl difluoro(2-methyl-3-oxocyclopentyl)methyl-
phosphonate (8a)
trans); 31P NMR (CDCl3, 161 MHz)
d 5.2 (t, J 107.9 Hz, 1P, cis), 4.6 (dd,
J 110.5, 106.3 Hz, 1P, trans); 13C NMR (CDCl3, 101 MHz)
d
210.2, 120.0
General procedure for the radical conjugate addition. To a stirred
solution of iododifluoromethylphosphonate 1a (100 mg,
0.29 mmol) and 3-methyl-2-cyclopentenone (0.035 mL,
0.35 mmol) in CH2Cl2 (2 mL) was added Et3B (0.35 mL, 1 M in
hexane, 1.2 equiv). After 1 h of stirring, Et3B was added (0.35 mL,
1 M in hexane,1.2 equiv) and the mixture was stirred additional 1 h.
The mixture was then concentrated under reduced pressure.
Compound 8a was isolated after flash chromatography (EtOAc/
pentane 4:6 to 5:5) as a colourless oil (62.7 mg, 69%). 1H NMR
(td, J 263.0, 214.0 Hz), 73.9 (d, J 6.9 Hz), 73.7 (d, J 7.0 Hz), 44.3, 30.8,
27.5, 25.0, 24.3 (d, J 3.3 Hz), 24.1 (d, J 3.5 Hz), 23.9 (d, J 5.2 Hz), 23.7
(d, J 4.5 Hz), 21.2, 21.1. MS-ESI (m/z) [MþH]þ 341 (8), 299 (32), 257
(100), 239 (15). HRMS-ESI (m/z) [MþH]þ calcd for C15H28O4F2P
341.1693, found 341.1690.
4.5. Diisopropyl difluoro(3-oxocyclopentyl)methyl-
phosphonate (5a)45
(CDCl3, 400 MHz)
6.3 Hz, 1H), 2.59e1.92 (m, 6H), 1.38 (d, J 6.1 Hz, 6H), 1.36 (d, J 6.1 Hz,
6H), 1.23 (d, J 6.8 Hz, 3H); 19F NMR (CDCl3, 376 MHz)
ꢁ110.79
(ddd, J 300.0, 108.5, 9.3 Hz, 1F), ꢁ119.91 (ddd, J 300.0, 108.5, 21.8 Hz,
1F); 31P NMR (CDCl3, 161 MHz) 4.6 (t, J 108.5 Hz, 1P); 13C NMR
(CDCl3, 101 MHz) 218.1, 120.9 (td, J 259.8, 215.1 Hz), 74.0 (d, J
d 4.86 (dsept, J 6.3, 6.3 Hz, 1H), 4.85 (dsept, J 6.3,
Following the general procedure used for 2a from iododi-
fluorophosphonate 1a (100.0 mg, 0.29 mmol), 2-cyclopentenone
(0.049 mL, 0.58 mmol), and Et3B (0.36 mL) in CH2Cl2 (2 mL),
compound 5a was isolated after flash chromatography (EtOAc/
pentane 5:5) as a colourless oil (49.3 mg, 56%). 1H NMR (CDCl3,
d
d
d
400 MHz)
d
4.85 (dsept, J 6.5, 6.5 Hz, 1H), 4.84 (dsept, J 6.5, 6.5 Hz,
7.2 Hz), 73.8 (d, J 7.2 Hz), 48.2 (td, J 20.0, 15.2 Hz), 43.5, 36.8, 24.2 (d,
J 3.3 Hz), 24.1 (d, J 3.7 Hz), 23.8 (d, J 4.8 Hz), 23.7 (d, J 4.9 Hz), 21.1
(td, J 3.7, 3.7 Hz), 15.1 (d, J 2.3 Hz). MS-ESI (m/z) [MþNa]þ 335 (22),
293 (44), 251 (100). HRMS-ESI (m/z) [MþNa]þ calcd for
C13H23O4F2PNa 335.1200, found 335.1216.
1H), 3.02e2.85 (m, 1H), 2.49e2.06 (m, 6H), 1.39e1.37 (m, 12H); 19F
NMR (CDCl3, 376 MHz)
d
ꢁ117.13 (ddd, J 298.0, 108.5, 17.1 Hz, 1F),
ꢁ118.83 (ddd, J 298.0, 108.5, 15.7 Hz, 1F); 31P NMR (CDCl3, 161 MHz)
d
4.8 (t, J 108.5 Hz, 1P); 13C NMR (CDCl3, 101 MHz)
d 216.1, 120.1 (td, J